Results 191 to 200 of about 698,336 (388)

Harnessing the Biological Responses Induced by Nanomaterials for Enhanced Cancer Therapy

Aggregate, EarlyView.
Nanomaterial (NM)‐induced toxicity can be strategically repurposed for cancer therapy. This review summarizes the mechanism by which NMs selectively activate specific cellular processes to regulate cell fate independently. We also discussed how NMs‐induced biological responses can be leveraged as therapeutic strategies for cancer treatment.
Liting Wang, Hao Fu, Jiangtao Lin, Meng Zhao, Chuanrong Chen, Hongze Liao, Yourong Duan   +6 more
wiley   +1 more source

PRIMARY OSTEOGENIC SARCOMA OF THE BLADDER

, 1943
Alice Crane, Roger Tremblay
openalex   +2 more sources

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.

The Lancet Oncology, 2017
H. Tawbi, M. Burgess, V. Bolejack, B. V. Van Tine, S. Schuetze, James Hu, S. D’Angelo, S. Attia, R. Riedel, D. Priebat, S. Movva, L. Davis, S. Okuno, D. Reed, J. Crowley, L. Butterfield, R. Salazar, J. Rodriguez-Canales, A. Lazar, I. Wistuba, L. Baker, R. Maki, D. Reinke, Shreyaskumar R Patel   +23 more
semanticscholar   +1 more source

Tebentafusp (IMCgp100) in the treatment of uveal melanoma — from preclinical evidence to clinical practice

Nowotwory
Tebentafusp (IMCgp100) is a novel bispecific immunotherapy that contains a specifically engineered soluble T-cellreceptor (TCR) capable of recognising the gp100 epitope on the surface of tumour cells presented by human leukocyteantigen-A*02:01 (HLA- A*02:
Piotr Remiszewski, Eryk Siedlecki, Julia Wąż, Kinga Filipek, Agata Pisklak, Wiktor Gaik, Monika Dudzisz-Śledź, Piotr Rutkowski, Anna M. Czarnecka   +8 more
doaj   +1 more source

Malignant lymphomas in transplantation patients: a review of the world experience. [PDF]

, 1970
Malignant lymphomas developed in 9 renal homograft recipients treated at widely separated transplantation centers. The development of these tumors appears to be an indirect complication of organ transplantation and/or the measures taken to prevent ...
Penn, I, Starzl, TE
core  

Tumor Auxiliary Prediction Strategy Based on Multiscale Feature Fusion in Medical Decision‐Making System

Advanced Intelligent Systems, EarlyView.
GA: MCFFS method architecture. Pathological images are processed by the multi‐level feature information fusion (MLFF) method and the multi‐scale feature map fusion strategy to achieve the recognition result of cell nuclei. The MLFF module contains convolution blocks, spatial self‐attention, and atrous spatial pyramid pooling.
Yingqing Lu, Jing Zhou, Fangfang Gou, Jia Wu   +3 more
wiley   +1 more source

SKELETAL MUSCLE SARCOMA

, 1934
Edgar M. Bick
openalex   +2 more sources

BLASTOMYCETOID BODIES IN A SARCOMA-LIKE TUMOR OF THE LEG [PDF]

, 1921
FREDERICK D. WEIDMAN
openalex   +1 more source

The Evolution and Recent Advances in Diagnostic Criteria for Idiopathic Multicentric Castleman Disease

American Journal of Hematology, EarlyView.
Idiopathic Multicentric Castleman Disease. ABSTRACT Idiopathic multicentric Castleman disease (iMCD) is a rare cytokine‐driven disorder characterized by systemic inflammation, organ dysfunction, and altered lymph node microscopic architecture. Over the past decade, diagnostic criteria have evolved significantly, integrating clinical, histopathological,
FNU Alnoor, Nicholas C. Spies, Jyoti Kumar, Peyman Samghabadi, Oscar Silva, Matt X. Luo, Karen M. Chisholm, Jingjing Zhang, Alexandra Rangel, David Ng, Peng Li, Robert S. Ohgami   +11 more
wiley   +1 more source

EXTENSIVE THORACOTOMY FOR SARCOMA OF THE CHEST-WALL WITH ADHESIONS TO THE LUNG [PDF]

, 1888
Roswell Park
openalex   +1 more source